Womenpreneur Middle East Staff

Dedicated editors fueling women's empowerment by crafting captivating narratives that inspire, inform, and celebrate their diverse journeys.

Newly approved Alzheimer’s drug may not work as well on women

Some experts are questioning whether a newly approved Alzheimer’s drug was shown in clinical trials to be less effective on women — even though the FDA didn’t flag any such concerns when it was authorized last week. Why it matters: Nearly two-thirds of Americans living with Alzheimer’s disease are female, according to the Alzheimer’s Association. The $26,500 drug, Leqembi,…

Read More